Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Oncology Stories

2014-04-03 11:16:23

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers. The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein...

2014-04-03 08:30:01

Joins Renowned Academic Scientists Charles Sawyers, Jose Baselga and Ronald Evans SAN DIEGO, April 3, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the expansion of the company's Clinical and Scientific Advisory Board (CSAB) and the appointment of Debasish Roychowdhury, M.D., who will serve as Seragon's Acting Chief Medical Officer....

2014-04-02 23:27:09

A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos. Raleigh, NC (PRWEB) April 02, 2014 A newly published report prepared by a team of medical oncologists in the UK says early recognition of bladder cancer symptoms could be the difference between life and death. A new article on the report has just been posted on the Cancer Monthly website and can be read by clicking here. Drs. Karen DeSouza, Simon Chowdhury and...

2014-04-02 12:31:57

Since 1993, Komen Columbus has raised more than $22.5 million to support local breast health programs and breast cancer research. COLUMBUS, Ohio, April 2, 2014 /PRNewswire/ -- Komen Columbus announced today it will grant $1.4 million to fund 21 programs that will provide thousands of women and men with life-saving breast health screening, education and treatment throughout the next year. "The needs that will be met with these 21 community health programs will fulfill vital needs in...

2014-04-02 12:31:39

New Program Brings Busy Moms Together to Get In Shape, Meet Other Moms and Raise Funds to Help Fight Cancer SAN FRANCISCO, April 2, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter has launched Moms In Training, a brand new nine-week workout program geared towards helping busy moms prepare for a 5K race, while meeting other moms in their community and raising funds for LLS's mission to fight blood cancer. Moms In Training is based...

2014-04-02 11:24:05

UCSF-Harvard study finds tests offer limited benefit to oldest female patients Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools. National guidelines recommend that doctors make individualized screening...

2014-04-02 10:46:54

Complex benefits and harms of mammography require individualized approach A comprehensive review of 50 year's worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated. And, since the relative benefits and harms of screening are related to a complex array of clinical factors and personal preferences, physicians and patients need more guidance on how best to...

2014-04-02 08:34:07

In complex cases, Medical University Innsbruck clinicians exploit speed and accuracy advantages of new groundbreaking linear accelerator INNSBRUCK, Austria, April 2, 2014 /PRNewswire/ -- Medical University Innsbruck is the first center in Austria to begin treating patients with Elekta's Versa HD(TM), a radiation therapy system equipped with advanced beam-shaping and high dose rate technologies to deliver extremely precise treatments in shorter treatment times. Since January 14, the...

2014-04-02 08:32:24

Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's leading molecular diagnostic...

2014-04-01 23:30:30

MRHFM comments on new study showing associations between all levels of asbestos exposure and mesothelioma, lung cancer and laryngeal cancer. St. Louis, MO (PRWEB) April 01, 2014 When asbestos fibers are breathed in, they may get trapped in the lungs where they may remain for a long period of time. A recent study published in the Journal of Occupational and Environmental Medicine (JOEM) in January 2014, reported that even small amounts of asbestos can remain in the body and cause a number...